# Diet Quality as an Associated Factor for Liver Function Enzyme Abnormalities Among Women of Reproductive Age

**Authors:** Fatehatun Noor, Nusrat Jahan Shorovi, Md. Mahadi Hasan Shoruve, Tasmim Fahima Ahmad, FNU Asamoni, Nisarga Bahar, Md. Ruhul Amin, Tanjina Rahman, Abu Ahmed Shamim, M Akhtaruzzaman

PMC · DOI: 10.7759/cureus.102608 · Cureus · 2026-01-29

## TL;DR

Poor diet quality is linked to abnormal liver enzymes in Bangladeshi women of reproductive age, suggesting dietary improvements could help prevent liver issues.

## Contribution

The study identifies low Food Consumption Score as a novel risk factor for elevated liver enzymes in this population.

## Key findings

- 28.7% of participants had elevated ALT and/or AST levels.
- Low Food Consumption Score significantly increased the odds of elevated liver enzymes.
- Higher saturated fat and cholesterol intake were associated with abnormal liver enzymes.

## Abstract

Background

Elevated liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), are early indicators of liver dysfunction in non-alcoholic fatty liver disease (NAFLD). The prevalence of NAFLD is increasing in Bangladesh, with studies indicating a higher prevalence among women. Additionally, rapid dietary transitions toward energy-dense foods rich in fat and sugar have contributed to the rising burden of non-communicable diseases. This study aimed to investigate the association between dietary intake, diet quality indicators, and elevated liver enzymes (ALT and AST) among women of reproductive age in Bangladesh.

Methods

A cross-sectional study was conducted among 240 women of reproductive age (15-49 years) randomly selected from community households in three selected districts of Bangladesh. Anthropometric and socioeconomic data were collected using standardized tools. Dietary intake was assessed using a single 24-hour dietary recall method and a Food Frequency Questionnaire (FFQ). Three complementary indices were applied to evaluate diet quality: Dietary Diversity (DD), Food Consumption Score (FCS), and the Bangladesh Healthy Eating Index (BD_HEI). The participant's blood was collected after overnight fasting. Serum ALT and AST levels were measured using a biochemical analyzer, and elevations in liver enzymes were defined according to standard clinical cut-off values. Descriptive and inferential statistics were performed using STATA version 15.1 (Stata Corp LLC, College Station, TX, USA).

Results

Among the 240 participants, 69 (28.7%) exhibited elevated ALT and/or AST levels, while 171 (71.3%) had normal values. Participants with elevated liver enzymes had higher intake of saturated fat (5.89 vs. 4.41 g, IQR: (3.84-9.63 vs. 2.98-7.15), p =0.010), cholesterol (55.21 vs. 30.41 mg, IQR: (15.21-137.92 vs. 0-106.61), p = 0.015). Participants with elevated liver enzymes had significantly lower FCS scores (23.2% vs. 9.4%, p = 0.014) but higher DD (27.5% vs. 15.8%, p = 0.036) as compared to normal liver enzymes. Multivariable logistic regression revealed that low FCS significantly increased the odds of elevated liver enzymes (AOR = 3.64, 95% CI: 1.53-8.62, p = 0.003).

Conclusion

This study highlights a significant association between poor FCS and liver enzyme abnormalities among Bangladeshi women of reproductive age. Integrating dietary quality interventions into reproductive health and noncommunicable disease (NCD) prevention programs could play a vital role in maintaining liver health and metabolic well-being in this vulnerable population.

## Linked entities

- **Diseases:** non-alcoholic fatty liver disease (MONDO:0013209)

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** NAFLD (MESH:D065626), insulin resistance (MESH:D007333), DD (MESH:D000740), liver disease (MESH:D008107), viral hepatitis (MESH:D014777), Micronutrient deficiencies (MESH:D007153), food insecurity (MESH:D005517), MDD (MESH:D003865), metabolic disorders (MESH:D008659), hepatic steatosis (MESH:D005234), liver dysfunction (MESH:D017093), NCDs (MESH:D000073296), abnormal liver function (MESH:D056486)
- **Chemicals:** MUFA (MESH:D005229), tocopherol (MESH:D024505), SFA (MESH:D005227), triglyceride (MESH:D014280), monounsaturated fat (-), zinc (MESH:D015032), sodium (MESH:D012964), PUFA (MESH:D005231), sugar (MESH:D000073893), phosphorus (MESH:D010758), salt (MESH:D012492), potassium (MESH:D011188), alcohol (MESH:D000438), folate (MESH:D005492), calcium (MESH:D002118), glucose (MESH:D005947), cholesterol (MESH:D002784), magnesium (MESH:D008274), vitamin B12 (MESH:D014805), Vitamin A (MESH:D014801), free fatty acids (MESH:D005230), iron (MESH:D007501), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949846/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949846/full.md

---
Source: https://tomesphere.com/paper/PMC12949846